Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001005794-05-000706

Chief Financial Officer acquired 11,364 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2005-08-31 Exercise or conversion : show line 1 in the form +11,364 $1.10 $12,500 11,364 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2005-08-31 Exercise or conversion : show line 2 in the form Incentive Stock Option (right to buy) −11,364 $1.10 2014-02-25 11,364 288,636 D
Loading xslF345X02/primary_doc.xml…